Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

QUEST DIAGNOSTICS

(DGX)
  Report
Real-time Estimate Cboe BZX  -  12:32 2022-09-28 pm EDT
125.35 USD   +2.48%
09/27Quest Diagnostics to Release Third Quarter 2022 Financial Results on October 20, 2022
PR
09/16FDA Authorizes Quest Diagnostics' Proprietary Monkeypox Test for Emergency Use
AQ
09/15Quest Diagnostics Teams Up With Lee Health to Deliver High-Value, Innovative Laboratory Services
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Quest Diagnostics Declares Quarterly Cash Dividend

08/10/2022 | 05:07pm EDT

SECAUCUS, N.J., Aug. 10, 2022 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.66 per share, payable on October 19, 2022 to shareholders of record of Quest Diagnostics common stock on October 4, 2022.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-301603825.html

SOURCE Quest Diagnostics


© PRNewswire 2022
All news about QUEST DIAGNOSTICS
09/27Quest Diagnostics to Release Third Quarter 2022 Financial Results on October 20, 2022
PR
09/16FDA Authorizes Quest Diagnostics' Proprietary Monkeypox Test for Emergency Use
AQ
09/15Quest Diagnostics Teams Up With Lee Health to Deliver High-Value, Innovative Laboratory..
PR
09/15Quest Diagnostics Teams Up with Lee Health to Deliver High-Value, Innovative Laboratory..
CI
09/14Achievers and Quest Diagnostics Win Gold in the 2022 Brandon Hall Group Excellence Tech..
BU
09/13Transcript : Quest Diagnostics Incorporated Presents at Morgan Stanley 20th A..
CI
09/13Quest Diagnostics to Perform Confirmatory Testing of Positive Breath Samples From Hound..
MT
09/13Hound Labs Forms Strategic Agreement with Quest Diagnostics
AQ
09/13Hound Labs Announces Agreement with Quest Diagnostics
CI
09/08Quest Diagnostics : Media Statement about COVID-19 and Monkeypox Testing
PU
More news
Analyst Recommendations on QUEST DIAGNOSTICS
More recommendations